4//SEC Filing
Preston Heather 4
Accession 0001209191-23-037096
CIK 0001805890other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 5:10 PM ET
Size
5.4 KB
Accession
0001209191-23-037096
Insider Transaction Report
Form 4
Preston Heather
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-14+17,000→ 17,000 totalExercise: $4.64Exp: 2033-06-13→ Common Stock (17,000 underlying)
Footnotes (1)
- [F1]This option fully vests on the earlier of (i) June 14, 2024 or (ii) the 2024 Annual Meeting of Shareholders of Fusion Pharmaceuticals Inc.
Documents
Issuer
Fusion Pharmaceuticals Inc.
CIK 0001805890
Entity typeother
Related Parties
1- filerCIK 0001606826
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 5:10 PM ET
- Size
- 5.4 KB